위내시경 기기 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Gastrointestinal Endoscopic Devices Market Size, Share & Trends Analysis Report By Type (Rigid GI Endoscopes, Flexible GI Endoscopes, Disposable GI Endoscopes), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,302,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,698,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,488,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

시장 규모 및 동향

세계 위내시경 기기 시장 규모는 2024년 112억 7,000만 달러로 추정되며, 2025-2030년까지 연평균 5.1%의 성장률을 보일 것으로 예상됩니다. 미국암협회에 따르면, 미국에서는 2022년 약 2만 6,380건의 위암 신규 사례가 보고되어 내시경 검사 등 진단 도구 강화에 대한 필요성이 높아지고 있습니다. 또한, 예테보리 대학의 다국적 연구에 따르면 전 세계적으로 40% 이상의 사람들이 기능성 위장(GI) 질환을 앓고 있어 내시경 시술에 대한 수요를 더욱 촉진하고 있습니다.

내시경 기술의 기술적 진보 또한 시장 성장을 촉진하는 데 중요한 역할을 하고 있습니다. 첨단 영상 시스템, 로봇 보조 장치, 향상된 시각화 도구와 같은 기술 혁신은 보다 정확한 진단과 효과적인 치료를 촉진합니다. 이러한 발전으로 인해 시술이 더욱 안전하고 효율적이 되어 임상 현장에서의 채택을 촉진하고 있습니다. 또한, 인공지능과 로봇 시스템을 내시경 검사에 통합하여 시술의 정확성과 효율성을 높이고 환자 결과를 개선할 수 있는 기회를 제공하고 있습니다.

최소침습 수술에 대한 선호도 또한 시장의 주요 촉진요인입니다. 북미에서는 대장 수술의 80%가 복강경 수술로 이뤄진다는 조사 결과도 있을 정도로 회복시간과 합병증을 줄이는 최소침습 수술로 전환이 진행되고 있습니다. 최소침습적 수술의 채택이 증가함에 따라 환자의 결과와 만족도가 향상될 것으로 예상됩니다.

또한, 브라질과 같은 국가에서는 공중보건 차원에서 대장내시경 검사가 증가하고 있으며, 지난 5년간 대장내시경 검진율이 약 25% 증가했다는 보고도 있습니다. 미국 예방의료작업반(Preventive Services Task Force)은 45세부터 정기적인 대장암 검진을 권장하고 있으며, 인식이 높아짐에 따라 2025년까지 성인의 검진 수검률이 15% 증가할 것으로 예상하고 있습니다. 이러한 노력은 내시경 수술에 대한 수요를 촉진하고 환자의 치료 성적을 향상시킬 것으로 기대됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 위내시경 기기 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 위내시경 기기 시장 : 유형 비즈니스 분석

• 유형 시장 점유율, 2024년과 2030년
• 유형 부문 대시보드
• 시장 규모와 예측과 동향 분석, 유형별, 2018-2030년
• 경질 위내시경
• 연질 위내시경
• 일회용 위내시경

제5장 위내시경 기기 시장 : 최종 용도 비즈니스 분석

• 최종 용도 시장 점유율, 2024년과 2030년
• 최종 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
• 병원
• 외래 시설

제6장 위내시경 기기 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 국가별, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 참여자 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요/상장 기업
  • Olympus Corporation
  • Boston Scientific Corporation
  • Medtronic
  • Johnson & Johnson Services, Inc.(Ethicon Inc.)
  • KARL STORZ SE &Co. KG
  • Fujifilm Holdings Corporation
  • Stryker
  • HOYA Corporation(PENTAX Medical)
  • Smith+Nephew
  • Cook
  • CONMED Corporation
  • Ambu A/S
  • Richard Wolf GmbH
  • STERIS plc

ksm

영문 목차

영문목차

Market Size & Trends:

The global gastrointestinal endoscopic devices market size was estimated at USD 11.27 billion in 2024 and is projected to grow at a CAGR of 5.1% from 2025 to 2030. According to the American Cancer Society, approximately 26,380 new cases of stomach cancer were reported in the U.S. in 2022, highlighting the ongoing need for enhanced diagnostic tools such as endoscopy. Moreover, a multinational study by the University of Gothenburg found that over 40% of individuals globally suffer from functional gastrointestinal (GI) disorders, further driving demand for endoscopic procedures.

Technological advancements in endoscopic technology are also playing a significant role in driving market growth. Innovations such as advanced imaging systems, robotic-assisted devices, and enhanced visualization tools facilitate more accurate diagnoses and effective treatments. These advancements make procedures safer and more efficient, driving their adoption in clinical settings. Furthermore, the integration of artificial intelligence and robotic systems into endoscopy is enhancing procedural accuracy and efficiency, providing opportunities for improved patient outcomes.

The preference for minimally invasive surgeries is another key driver of the market. Studies have shown that laparoscopic techniques are used in nearly 80% of colorectal surgeries in North America, reflecting a broader shift toward less invasive options that reduce recovery times and complications. The increasing adoption of minimally invasive techniques is expected to enhance patient outcomes and satisfaction.

Furthermore, public health initiatives in countries such as Brazil have led to a rise in colonoscopy screenings, with reports showing an increase of approximately 25% in screening rates over the past five years. The U.S. Preventive Services Task Force recommends regular screening for colorectal cancer starting at age 45, contributing to a projected increase in screening participation rates among adults by 15% by 2025 as awareness grows. These initiatives are expected to drive demand for endoscopic procedures and enhance patient outcomes.

Global Gastrointestinal Endoscopic Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global gastrointestinal endoscopic devices market report based on type, end use, and region:

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Rigid Gastrointestinal Endoscopes
  • Gastroscope (Upper GI Endoscope)
  • Enteroscope
  • Sigmoidoscope
  • Duodenoscope
• Flexible Gastrointestinal Endoscopes
  • Gastroscope (Upper GI Endoscope)
  • Enteroscope
  • Sigmoidoscope
  • Duodenoscope
  • Colonoscope
• Disposable Gastrointestinal Endoscopes
  • Gastroscope (Upper GI Endoscope)
  • Enteroscope
  • Sigmoidoscope
  • Duodenoscope
  • Colonoscope
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Gastrointestinal Endoscopic Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Gastrointestinal Endoscopic Devices Market: Type Business Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Rigid Gastrointestinal Endoscopes
  • 4.4.1. Rigid Gastrointestinal Endoscopes Market, 2018 - 2030 (USD Million)
  • 4.4.2. Gastroscope (Upper GI Endoscope)
    • 4.4.2.1. Gastroscope (Upper GI Endoscope) Market, 2018 - 2030 (USD Million)
  • 4.4.3. Enteroscope
    • 4.4.3.1. Enteroscope Market, 2018 - 2030 (USD Million)
  • 4.4.4. Sigmoidoscope
    • 4.4.4.1. Sigmoidoscope Market, 2018 - 2030 (USD Million)
  • 4.4.5. Duodenoscope
    • 4.4.5.1. Duodenoscope Market, 2018 - 2030 (USD Million)
• 4.5. Flexible Gastrointestinal Endoscopes
  • 4.5.1. Flexible Gastrointestinal Endoscopes Market, 2018 - 2030 (USD Million)
  • 4.5.2. Gastroscope (Upper GI Endoscope)
    • 4.5.2.1. Gastroscope (Upper GI Endoscope) Market, 2018 - 2030 (USD Million)
  • 4.5.3. Enteroscope
    • 4.5.3.1. Enteroscope Market, 2018 - 2030 (USD Million)
  • 4.5.4. Sigmoidoscope
    • 4.5.4.1. Sigmoidoscope Market, 2018 - 2030 (USD Million)
  • 4.5.5. Duodenoscope
    • 4.5.5.1. Duodenoscope Market, 2018 - 2030 (USD Million)
  • 4.5.6. Colonoscope
    • 4.5.6.1. Colonoscope Market, 2018 - 2030 (USD Million)
• 4.6. Disposable Gastrointestinal Endoscopes
  • 4.6.1. Disposable Gastrointestinal Endoscopes Market, 2018 - 2030 (USD Million)
  • 4.6.2. Gastroscope (Upper GI Endoscope)
    • 4.6.2.1. Gastroscope (Upper GI Endoscope) Market, 2018 - 2030 (USD Million)
  • 4.6.3. Enteroscope
    • 4.6.3.1. Enteroscope Market, 2018 - 2030 (USD Million)
  • 4.6.4. Sigmoidoscope
    • 4.6.4.1. Sigmoidoscope Market, 2018 - 2030 (USD Million)
  • 4.6.5. Duodenoscope
    • 4.6.5.1. Duodenoscope Market, 2018 - 2030 (USD Million)
  • 4.6.6. Colonoscope
    • 4.6.6.1. Colonoscope Market, 2018 - 2030 (USD Million)

Chapter 5. Gastrointestinal Endoscopic Devices Market: End Use Business Analysis

• 5.1. End Use Market Share, 2024 & 2030
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 5.5. Outpatient Facilities
  • 5.5.1. Outpatient Facilities Market, 2018 - 2030 (USD Million)

Chapter 6. Gastrointestinal Endoscopic Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Gastrointestinal Endoscopic Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Olympus Corporation
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Product Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. Boston Scientific Corporation
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Product Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Medtronic
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Product Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Johnson & Johnson Services, Inc. (Ethicon Inc.)
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Product Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. KARL STORZ SE & Co. KG
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Product Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Fujifilm Holdings Corporation
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Product Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Stryker
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Product Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. HOYA Corporation (PENTAX Medical)
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Product Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Smith+Nephew
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Product Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Cook
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Product Benchmarking
    • 7.5.10.4. Strategic Initiatives
  • 7.5.11. CONMED Corporation
    • 7.5.11.1. Overview
    • 7.5.11.2. Financial Performance
    • 7.5.11.3. Product Benchmarking
    • 7.5.11.4. Strategic Initiatives
  • 7.5.12. Ambu A/S
    • 7.5.12.1. Overview
    • 7.5.12.2. Financial Performance
    • 7.5.12.3. Product Benchmarking
    • 7.5.12.4. Strategic Initiatives
  • 7.5.13. Richard Wolf GmbH
    • 7.5.13.1. Overview
    • 7.5.13.2. Financial Performance
    • 7.5.13.3. Product Benchmarking
    • 7.5.13.4. Strategic Initiatives
  • 7.5.14. STERIS plc
    • 7.5.14.1. Overview
    • 7.5.14.2. Financial Performance
    • 7.5.14.3. Product Benchmarking
    • 7.5.14.4. Strategic Initiatives

관련자료